FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and concerns oxygen-transport blood substitutes, namely to a polyfunctional polyhemoglobin-enzyme complex consisting of polyhemoglobin molecules of various compositions of molecular mass in the range 300-3300 kDa produced with the use of glutaric aldehyde.
EFFECT: invention provides production of the blood substitute with optimum oxygen-transport properties and functioning time in a circulatory bed without involving kidneys, inducing erythrocyte aggregation, and also causing osmotic vascular pressure failure; the blood substitute exhibit antioxidant, vasodilating and antithrombotic properties.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
BLOOD SUBSTITUTE WITH FUNCTION OF OXYGEN TRANSFER, PHARMACEUTICAL COMPOSITION (VERSIONS) | 2008 |
|
RU2361608C1 |
METHOD FOR PREPARING POLYMER MODIFIED HEMOGLOBIN | 2012 |
|
RU2504387C2 |
BLOOD SUBSTITUTE AS OXYGEN TRANSPORTER, COMPOSITION FOR ITS PREPARING AND METHOD OF POLYMERIC MODIFIED HEMOGLOBIN PREPARING | 1999 |
|
RU2162707C2 |
METHOD OF BLOOD SUBSTITUTE PRODUCTION AND RELATED INSTALLATION FOR METHOD IMPLEMENTATION | 2007 |
|
RU2341286C1 |
BLOOD SUBSTITUTE WITH FUNCTION OF OXYGEN TRANSFER | 2007 |
|
RU2340354C1 |
POLYMERISED HAEMOGLOBIN SOLUTIONS WITH LOWERED TETRAMER CONTENT AND METHOD OF PRODUCTION THEREOF | 2004 |
|
RU2337705C2 |
METHOD OF MEDICAL TREATMENT OF PATIENTS WITH HEAVY BLOOD LOSS | 2003 |
|
RU2325924C2 |
METHOD OF PREPARING POLYHEMOGLOBIN SHOWING ENHANCED OXYGEN-TRANSPORTING EFFECTIVENESS | 1996 |
|
RU2132687C1 |
USE OF POLYMERIZED HEMOGLOBIN FOR INCREASING EFFICIENCY OF MALIGNANT TUMOR CHEMOTHERAPY | 2021 |
|
RU2789607C1 |
USE OF POLYMERIZED HEMOGLOBIN FOR MOBILIZATION OF BLOOD FROM DEPOT IN CASE OF BLOOD LOSS | 2021 |
|
RU2811253C2 |
Authors
Dates
2011-10-27—Published
2010-02-24—Filed